Home
NovoCure NVCR paid Tarplin, Downs & Young $80K for lobbying in Q2 2026 · Medicare, Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q2 2026
- Stock
- NovoCure NVCR
- Client
- Novocure
- Reported
- 26/07/20
Up 0.0% from last quarter
What else happened in NovoCure around then
Filed or reported within 30 days of the trade day · 05/31~07/30Novocure's other lobbying reports
- Novocure
LobbyingNovoCure
LobbyingNovoCure
NVCR
$60K
$60K
Reported 07/20
for Q2
- Novocure
LobbyingNovoCure
LobbyingNovoCure
NVCR
$20K
$20K
Reported 07/20
for Q2
- Novocure
LobbyingNovoCure
LobbyingNovoCure
NVCR
$160K
$160K
Reported 07/19
for Q2
- Novocure
LobbyingNovoCure
LobbyingNovoCure
NVCR
$40K
$40K
Reported 04/20
for Q1
- Novocure
LobbyingNovoCure
LobbyingNovoCure
NVCR
$80K
$80K
Reported 04/20
for Q1